Cargando…
Moving forward in clinical research with master protocols
With billions of dollars in research and development (R&D) funding continuing to be invested, the novel coronavirus disease 2019 (COVID-19) has become into a singular focus for the scientific community. However, the collective response from the scientific communities have seen poor return on inv...
Autores principales: | Park, Jay J.H., Dron, Louis, Mills, Edward J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120789/ https://www.ncbi.nlm.nih.gov/pubmed/34000408 http://dx.doi.org/10.1016/j.cct.2021.106438 |
Ejemplares similares
-
Reporting of master protocols towards a standardized approach: A systematic review
por: Siden, Ellie G., et al.
Publicado: (2019) -
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
por: Park, Jay J. H, et al.
Publicado: (2019) -
Synthetic and External Controls in Clinical Trials – A Primer for Researchers
por: Thorlund, Kristian, et al.
Publicado: (2020) -
Clinical Trial Data Sharing for COVID-19–Related Research
por: Dron, Louis, et al.
Publicado: (2021) -
Ginsenosides: the need to move forward from bench to clinical trials
por: Yu, Seung Eun, et al.
Publicado: (2019)